These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29729083)

  • 1. Hydrocortisone inhibition of wild-type and αD200Q nicotinic acetylcholine receptors.
    Dworakowska B; Nurowska E; Dołowy K
    Chem Biol Drug Des; 2018 Sep; 92(3):1610-1617. PubMed ID: 29729083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of muscle nicotinic acetylcholine receptors by the glucocorticoid hydrocortisone. Possible allosteric mechanism of channel blockade.
    Bouzat C; Barrantes FJ
    J Biol Chem; 1996 Oct; 271(42):25835-41. PubMed ID: 8824214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of acetylcholine receptor channel kinetics by hydrocortisone.
    Nurowska E; Ruzzier F
    Biochim Biophys Acta; 2002 Aug; 1564(1):14-20. PubMed ID: 12100991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of threonine 422 in transmembrane domain alpha M4 of the nicotinic acetylcholine receptor as a possible site of interaction with hydrocortisone.
    Garbus I; Roccamo AM; Barrantes FJ
    Neuropharmacology; 2002 Jul; 43(1):65-73. PubMed ID: 12213260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist self-inhibitory binding site of the nicotinic acetylcholine receptor.
    Arias HR
    J Neurosci Res; 1996 Apr; 44(2):97-105. PubMed ID: 8723217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Determinants of α3β4 Nicotinic Acetylcholine Receptors Inhibition by Triterpenoids.
    Eom S; Kim YS; Lee SB; Noh S; Yeom HD; Bae H; Lee JH
    Biol Pharm Bull; 2018; 41(1):65-72. PubMed ID: 29311484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
    Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
    Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors.
    Arias HR; Bhumireddy P; Bouzat C
    Int J Biochem Cell Biol; 2006; 38(8):1254-76. PubMed ID: 16520081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors.
    Arias HR; De Rosa MJ; Bergé I; Feuerbach D; Bouzat C
    Biochemistry; 2013 Nov; 52(47):8480-8. PubMed ID: 24164482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Mol Membr Biol; 1996; 13(1):1-17. PubMed ID: 9147657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dinoflagellate Toxin 20-Methyl Spirolide-G Potently Blocks Skeletal Muscle and Neuronal Nicotinic Acetylcholine Receptors.
    Couesnon A; Aráoz R; Iorga BI; Benoit E; Reynaud M; Servent D; Molgó J
    Toxins (Basel); 2016 Aug; 8(9):. PubMed ID: 27563924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel agonist effect on the nicotinic acetylcholine receptor exerted by the anticonvulsive drug Lamotrigine.
    Vallés AS; Garbus I; Antollini SS; Barrantes FJ
    Biochim Biophys Acta; 2008 Oct; 1778(10):2395-404. PubMed ID: 18621019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the agonist domain of the nicotinic acetylcholine receptor by cysteine scanning mutagenesis reveals residues in proximity to the alpha-bungarotoxin binding site.
    Spura A; Russin TS; Freedman ND; Grant M; McLaughlin JT; Hawrot E
    Biochemistry; 1999 Apr; 38(16):4912-21. PubMed ID: 10213592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of valine 7' of TMD2 to gating of neuronal alpha3 receptor subtypes.
    Nieves-Cintrón M; Caballero-Rivera D; Navedo MF; Lasalde-Dominicci JA
    J Neurosci Res; 2006 Dec; 84(8):1778-88. PubMed ID: 17044037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of steroid hormones on nicotinic acetylcholine receptor channel kinetics].
    Nurowska E; Dworakowska B; Dołowy K
    Postepy Hig Med Dosw; 2000; 54(3):363-70. PubMed ID: 10941270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoactivated 3-azioctanol irreversibly desensitizes muscle nicotinic ACh receptors via interactions at alphaE262.
    Forman SA; Zhou QL; Stewart DS
    Biochemistry; 2007 Oct; 46(42):11911-8. PubMed ID: 17910479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of nicotinic acetylcholine receptors by bicuculline.
    Demuro A; Palma E; Eusebi F; Miledi R
    Neuropharmacology; 2001 Dec; 41(7):854-61. PubMed ID: 11684149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of the nicotinic acetylcholine response in rat superior cervical ganglionic neurons by steroids.
    Uki M; Nabekura J; Akaike N
    J Neurochem; 1999 Feb; 72(2):808-14. PubMed ID: 9930757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.